News
-
-
-
-
PRESS RELEASE
DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies
DiNAQOR and academic partners introduce groundbreaking percutaneous platform for organ-specific delivery of advanced therapies, addressing critical challenges in gene and cell therapy development -
-
-
-
PRESS RELEASE
FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner
FDA approves Formycon's Nufymco® as interchangeable Ranibizumab Biosimilar, partnering with Zydus for commercialization in the US, expanding access to retinal therapies -
-
PRESS RELEASE
VOLUNTARY UPDATE: DISPOSAL OF VDE HOUSING ESTATE AND ACQUISITION OF REMAINING INTEREST IN ORBIT AFRICA LOGISTICS FOR A NOMINAL CONSIDERATION
Grit Real Estate Income Group provides voluntary update on disposal of VDE Housing Estate and acquisition of remaining interest in Orbit Africa Logistics for a nominal consideration
